The FDA is preparing to respond should bird flu begin circulating more widely among humans, though the threat the disease currently poses to humans remains low, the agency’s commissioner Robert Califf, MD, told senators May 8.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
